Target intelligence / Profile preview

Panton-Valentine leukocidin subunit S (LukS-PV)

Target
LukS-PV
Molecular classification
Pore-forming toxin, Bacterial exotoxin
01

Overview

Panton-Valentine leukocidin subunit S (LukS-PV) is one component of the bicomponent Panton-Valentine leukocidin (PVL) toxin produced by Staphylococcus aureus. It works in conjunction with the F subunit (LukF-PV) to form pores in the membranes of host cells, particularly leukocytes. The protein has a structure consisting of three functional subdomains: a central β-sandwich, a protruding rim, and a stem domain that is critical for pore formation[1][3]. LukS-PV specifically binds to the human C5a receptor (hC5aR1) on target cells, while LukF-PV interacts with CD45, and together they form an octameric pore structure with alternating S and F components[4]. This pore formation leads to cell lysis and contributes to the pathogenicity of PVL-producing S. aureus strains. The signal peptide of LukS-PV has been shown to mediate increased adhesion to heparan sulfates[5]. LukS-PV has been directly implicated in the pathophysiology of necrotizing pneumonia, where it can be detected in lung sections of affected patients. It induces apoptosis by targeting mitochondria, causing the release of cytochrome c and other pro-apoptotic factors, leading to caspase activation and DNA fragmentation[2]. This process occurs independently of Bax, a pro-apoptotic protein typically involved in mitochondrial pore formation.

Other names
PVL S-componentLukS-PV
02

Mechanism of action

Forms heterooligomeric pores with LukF-PV in target cell membranes Binds to C5a receptor (hC5aR1) on target cells Interacts with heparan sulfates via signal peptide Targets mitochondria to induce apoptosis

03

Biological functions

Pore formation in cell membranesLeukocyte destructionInduction of apoptosisMitochondrial targeting
04

Disease associations

InfectionNecrotizing pneumoniaDermonecrosis
05

Safety considerations

Associated with high mortality (nearly 75% in necrotizing pneumonia)Causes severe tissue damage and inflammationContributes to antibiotic-resistant infections
06

Biomarkers

Detection of LukS-PV in lung sections of patients with necrotizing pneumonia

Beyond the preview

Go deeper on Panton-Valentine leukocidin subunit S (LukS-PV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panton-Valentine leukocidin subunit S (LukS-PV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call